Data / Form D filings / Savara Inc
Savara Inc: Form D filings
Savara Inc, a pharmaceuticals company in Austin, TX, filed 2 Form D notices with the SEC between 2014 and 2020. The latest, on January 2, 2020, reports $26.8 million sold of a $75 million offering to 18 investors.
Find out what Savara Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6836 Bee Cave Road, Building III, Suite 200, Austin, TX, 78746
- Phone
- (512) 961-1891
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1160308
The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 2, 2020 | New notice | $74,999,962 | $26,779,912 | $48,220,050 | 18 | Dec 24, 2019 | sec.gov |
| Mar 5, 2014 | New notice | $4,162,089 | $4,162,089 | $0 | 2 | Feb 27, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Richard J. Hawkins | Director | |
| An J. van Es-Johansson | Director | |
| Ricky J. Sun | Director | |
| Taneli J. Jouhikainen | Executive Officer | |
| Mike J. Ciesla | Executive Officer | |
| Badrul J. Chowdhury | Executive Officer | |
| John J. Lord | Executive Officer | |
| Peter J. Ginsburg | Executive Officer | |
| Kate J. McCabe | Executive Officer | |
| Nevan S. Elam | Director | |
| Joseph S. McCracken | Director | |
| Matthew A. Pauls | Director | |
| David A. Ramsay | Director | |
| Robert Neville | Executive Officer, Director | |
| David L. Lowrance | Executive Officer |
Other pharmaceuticals companies in Texas that filed recently
- LUCIER PHARMACEUTICALS INC offering · Oct 13, 2026
- FibroBiologics, Inc. $1.2 million · Oct 13, 2026
- Eos SENOLYTIX, Inc. $750,000 · Aug 27, 2026
Every Form D from the week of Dec 30, 2019 · All recent filings in Texas · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Savara Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.